CONCORD DRUGS
|
The Current P/S Ratio of CONCORD DRUGS is 1.12.
| Share Price | ₹73.0 | Nov 12,2026 |
| Market Cap | ₹96.3 Cr | |
| Sales-TTM | ₹86.1 Cr | TTM-Consolidated Results |
| Price/Sales | 1.12x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of CONCORD DRUGS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹96.3 Cr] as on Nov 12,2026
(/) Sales [ ₹86.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.12x ]
Thus, for CONCORD DRUGS , the investors are currently willing to pay '1.12 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD DRUGS !
The chart below summarizes the trend in P/S Ratio of CONCORD DRUGS over the last five years.
Historical PS (Price/Sales) ratio chart of CONCORD DRUGS
PS Ratio Performance Analysis for CONCORD DRUGS
- CONCORD DRUGS 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 0.60x.
- CONCORD DRUGS 's operated at median p/e ratio of 0.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, CONCORD DRUGS 's p/e ratio peaked in Mar2024 at 0.78x.
- CONCORD DRUGS 's p/e ratio hit its five-year low in Mar2022 of 0.43x.
How does CONCORD DRUGS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| CONCORD DRUGS | 86.1 | 1.12 | 96.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 61,630.9 | 7.35 | 452,707.0 |
| DIVIS LABORATORIES LTD | 12,191.0 | 24.93 | 303,962.0 |
| TORRENT PHARMACEUTICALS LTD | 17,400.0 | 10.32 | 179,494.0 |
| CIPLA LTD | 28,138.9 | 4.05 | 113,912.0 |
| DR REDDYS LABORATORIES LTD | 33,097.4 | 3.50 | 115,769.0 |
| MANKIND PHARMA LTD | 15,378.6 | 7.08 | 108,837.0 |
| LUPIN LTD | 30,746.3 | 3.00 | 92,098.8 |
| ZYDUS LIFESCIENCES LTD | 30,378.1 | 3.96 | 120,249.0 |
| AUROBINDO PHARMA LTD | 36,912.9 | 2.81 | 103,856.0 |
| LAURUS LABS LTD | 7,822.5 | 16.54 | 129,410.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD DRUGS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.12x |
| Max industry PS | 24.93x |
| Median industry PS | 4.05x |
| Average industry PS | 7.70x |
You may also like the below Video Courses